Position in JNJ
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,085,241
-$3,515,869 QoQ
Shares Held
20,023
-43.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#1,606
of 4,676 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Northwest & Ethical Investments L.P. holds $150,710,322 across 7 Drug Manufacturers - General names. JNJ ranks #6 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
311,108 | $39,977,378 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
294,685 | $37,230,502 | |
| 3 | LLY |
ELI LILLY & Co
|
27,350 | $32,804,413 | |
| 4 | ABBV |
AbbVie Inc.
|
118,057 | $29,707,863 | |
| 5 | PFE |
Pfizer Inc
|
221,058 | $5,323,076 | |
| 6 | JNJ |
Johnson & Johnson
This page
|
20,023 | $5,085,241 | |
| 7 | BIIB |
Biogen Inc.
|
2,693 | $581,849 |
All Filings in JNJ
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,085,241 | 20,023 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $8,601,110 | 35,187 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $11,460,063 | 55,376 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $10,407,068 | 56,127 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $9,398,249 | 61,527 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $5,128,602 | 30,925 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $9,403,770 | 65,024 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $7,492,033 | 46,230 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $7,234,627 | 49,498 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $6,560,455 | 41,472 | Shares | Sole | 2025-07-09 | |
| 2023-12-31 | $4,008,155 | 25,572 | Shares | Sole | 2025-07-09 | |
| 2023-03-31 | $3,968,930 | 25,606 | Shares | Sole | 2025-07-09 | |
| 2022-12-31 | $20,276,240 | 114,782 | Shares | Sole | 2025-07-09 | |
| 2022-09-30 | $17,207,852 | 105,337 | Shares | Sole | 2025-07-09 | |
| 2022-06-30 | $19,626,748 | 110,567 | Shares | Sole | 2025-07-09 | |
| 2022-03-31 | $16,006,881 | 90,317 | Shares | Sole | 2025-07-09 | |
| 2021-12-31 | $17,021,636 | 99,501 | Shares | Sole | 2025-07-09 | |
| 2021-09-30 | $12,508,336 | 77,451 | Shares | Sole | 2025-07-09 | |
| 2021-06-30 | $19,256,293 | 116,889 | Shares | Sole | 2025-07-09 | |
| 2021-03-31 | $20,813,284 | 126,640 | Shares | Sole | 2025-07-09 | |
| 2020-12-31 | $14,828,028 | 94,218 | Shares | Sole | 2025-07-08 | |
| 2020-09-30 | $13,995,166 | 94,003 | Shares | Sole | 2025-07-08 | |
| 2020-06-30 | $13,398,804 | 95,277 | Shares | Sole | 2025-07-08 | |
| 2020-03-31 | $11,053,078 | 84,291 | Shares | Sole | 2025-07-08 | |
| No filing history on record for this holder in this stock. | ||||||